SCHEMBL6170748

SCHEMBL6170748

COc1ccc(-c2noc(Cc3ccccc3)c2-c2ccc(S(N)(=O)=O)cc2)cc1F

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 19/20 0.55
PTGS1 P23219 11/20 0.55
CA2 P00918 2/20 0.47
CA9 Q16790 2/20 0.47
CA12 O43570 1/20 0.47
MT-CO2 P00403 1/20 0.47
CA1 P00915 1/20 0.47
LMNA P02545 1/20 0.47
CA3 P07451 1/20 0.47
ADRB2 P07550 1/20 0.47
ADRB1 P08588 1/20 0.47
CYP3A4 P08684 1/20 0.47
ADORA3 P0DMS8 1/20 0.47
CHRM1 P11229 1/20 0.47
ADRA2B P18089 1/20 0.47
CA4 P22748 1/20 0.47
CA6 P23280 1/20 0.47
SLC6A2 P23975 1/20 0.47
PDE4A P27815 1/20 0.47
ADORA1 P30542 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6168095 0.90 PTGS2 (0.53) PTGS2PTGS1CA2CA9CA12
SCHEMBL6168801 0.87 PTGS2 (0.55) PTGS2PTGS1
SCHEMBL8480053 0.87 PTGS2 (0.47) PTGS2PTGS1CA2CA9CA4
SCHEMBL6168179 0.87 PTGS2 (0.53) PTGS2PTGS1CA2CA9CA12
SCHEMBL6171523 0.86 PTGS2 (0.54) PTGS2PTGS1
SCHEMBL27539938 0.85 PTGS2 (0.54) PTGS2PTGS1CA2CA9CA12
SCHEMBL6170018 0.84 PTGS2 (0.52) PTGS2PTGS1
SCHEMBL4888033 0.84 PTGS2 (0.53) PTGS2PTGS1
SCHEMBL6168610 0.83 PTGS2 (0.51) PTGS2PTGS1
SCHEMBL6170005 0.83 PTGS2 (0.50) PTGS2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1528059-A2 Substituted isoxazoles for the treatment of inflammation G.D. Searle LLC (US) 2005-05-04 EP disclosed
CN-1442139-A Medicinal composition for treating inflammation SEARLE & CO (US) 2003-09-17 CN disclosed
CN-1107058-C Substituted isoxazoles for the treatment of disorders SEARLE & CO (US) 2003-04-30 CN disclosed
EP-1223167-A2 Substituted isoxazoles for the treatment of inflammation G.D. Searle & Co. (US) 2002-07-17 EP disclosed
US-5985902-A TREATING INFLAMMATION AND INFLAMMATION-ASSOCIATED DISORDERS, SUCH AS ARTHRITIS G.D. SEARLE & CO. (US) 1999-11-16 US disclosed
CN-1181075-A Substituted isoxazoles for the treatment of disorders SEARLE & CO (US) 1998-05-06 CN disclosed
EP-0809636-A1 SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-12-03 EP disclosed
US-5633272-A Substituted isoxazoles for the treatment of inflammation PHARMACIA & UPJOHN COMPANY LLC 1997-05-27 US disclosed
WO-1996025405-A1 SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-08-22 WO disclosed